Acalypha australis L. and colistin-containing compound medicine for livestock and poultry

Abstract

The invention relates to an Acalypha australis L. and colistin-containing compound medicine for livestock and poultry. The compound medicine comprises, by weight, 3-30 parts of colistin and 5-200 parts of Acalypha australis L.. Researches prove that an antibiotic medicine containing Acalypha australis L. can reverse the drug resistance of bacteria to the antibiotic medicine in order to improve the treatment effect of the antibiotic medicine. The compound medicine can be processed through routine methods to prepare powder, a tablet, an oral liquid or a granule, and the compound medicine is added to a livestock and poultry feed according to a main medicine/feed ratio of 0.1-7g/kg to be used for feeding, so the medicine use cost and medicinal residues are greatly reduced, high economic benefits are created for farmers, and the food safety is ensured.

Description

technical field

[0001] The invention belongs to the technical field of treatment of Escherichia coli infection in livestock and poultry, and in particular relates to a compound medicine for livestock and poultry containing Guangxi Yao medicine Herba chinensis and colistin. Background technique

[0002] Escherichia coli is a common conditional pathogen and a common disease. It can cause acute sepsis, peritonitis, hepatitis, pneumonia, enteritis and other severe infections in chickens, and can also be secondary or mixed with viral diseases. , causing huge economic losses to the farming industry. Amoxicillin, ampicillin, ceftiofur, ceftriaxone, amoxicillin / clavulanic acid, ampicillin / sulbactam and other β-lactam ring antibiotics are commonly used important drugs for the prevention and treatment of this disease. The degree of scale intensification is increasing, and the use of drugs is becoming more and more widespread. There are more and more drug-resistant strains, and there ...

Images